Population Pharmacokinetics of Gentamicin in Neonates Using a Nonlinear, Mixed‐Effects Model
- 6 May 1992
- journal article
- research article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 12 (3) , 178-182
- https://doi.org/10.1002/j.1875-9114.1992.tb04506.x
Abstract
The population pharmacokinetics of gentamicin in neonates was determined using a nonlinear, mixed-effects model (NONMEM). The final regression equations derived to estimate clearance (Cl) and volume of distribution (Vd) were Cl = 0.120 * (WT/2.4)1.36 L/hr and Vd = 0.429 * (WT) L. The interindividual variability (% CV) for clearance was 26.2% and for volume of distribution 15.9%. Intraindividual variability was 11.0%. In a separate group of 30 neonates, the predictive ability of the NONMEM-generated population variables was compared to the predictions from a standard two-stage population analysis. The trough concentrations predicted using NONMEM-generated parameters were significantly less biased and more precise; there were no significant differences between the methods in predicting peaks. NONMEM is a useful tool for determining population pharmacokinetics and appears to be consistent across populations using routine clinical data and limited observation.This publication has 10 references indexed in Scilit:
- Population PharmacokineticsThe Journal of Clinical Pharmacology, 1988
- Population Pharmacokinetics of Gentamicin in NeonatesDevelopmental Pharmacology and Therapeutics, 1988
- Population PharmacokineticsClinical Pharmacokinetics, 1986
- Estimation of gentamicin clearance and volume of distribution in neonates and young children.British Journal of Clinical Pharmacology, 1984
- Gentamicin Dosing in the NewbornDevelopmental Pharmacology and Therapeutics, 1984
- The Need for Pharmacokinetic Monitoring of Gentamicin Therapy in Critically III NeonatesDevelopmental Pharmacology and Therapeutics, 1984
- Pharmacokinetic Study of Gentamicin in Preterm and Term NeonatesDevelopmental Pharmacology and Therapeutics, 1984
- Evaluation of methods for estimating population pharmacokinetic parameters. III. Monoexponential model: Routine clinical pharmacokinetic dataJournal of Pharmacokinetics and Biopharmaceutics, 1983
- Some suggestions for measuring predictive performanceJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Estimation of population characteristics of pharmacokinetic parameters from routine clinical dataJournal of Pharmacokinetics and Biopharmaceutics, 1977